Managers of Louisiana’s state-sponsored health plans would have denied coverage for Vioxx prescriptions if they’d known the drug posed a greater heart-attack risk than rival medicines, David Hood, the former head of the Department of Health and Hospitals, said today in the trial of the state’s lawsuit against Merck. Louisiana seeks to recover as much as $20 million as a refund for those prescriptions.
“If we had known the risk outweighed the benefit and the drug posed a threat to health, we would have done everything we could” to bar reimbursements of Vioxx prescriptions, Hood told a federal judge in New Orleans. It’s the first of more than a dozen refund cases filed by states over Vioxx to go to trial.
Entradas
No hay comentarios:
Publicar un comentario